IL-22 upregulates gastrin-releasing peptide receptor expression in keratinocytes of the skin (46), which is key in mediating both non-histaminergic and pathologic itch (47, 48), thus affecting the itch symptoms in AD itch symptoms in patients. This evidence concerns the gene IL22 and Alzheimer disease.